Atlas Trials

Very-Low Risk Myelodysplastic Syndrome

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Very-Low Risk Myelodysplastic Syndrome

RecordFirmDate
A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome (NCT04718844)Silence Therapeutics plc2021-04-14

Track Very-Low Risk Myelodysplastic Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.